| |
|
|
|
ASLAN Pharmaceuticals Limited  
|
|
2 0.17 (0.09%) |
09-13 15:57 |
|
Open: |
1.9412 |
Pre close: |
1.83 |
Target:
|
2.97
|
|
High: |
2.67 |
Low: |
1.9412 |
Resistance:
|
2.54
3.18
|
|
Volume: |
152,383 |
Market Cap: |
60M |
Support:
|
1.50
1.25
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.78
 |
MACD |
MACD(12,26):
|
-0.26 |
|
MA(20): |
1.88  |
Signal(12,26,9): |
-0.33 |
|
MA(100): |
3.09 |
Stochastic Oscillator |
%K(14,3):
|
34.13 |
|
MA(250): |
4.13 |
%D(3): |
26.76 |
|
Average Volume(K) |
3-Month: |
2249
|
52-Week |
High:
|
8.07 |
|
10-Days: |
4414 |
Low: |
1.50 |
|
RSI |
RSI(14):
|
47.24 |
Change(%): |
-73.9 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.045 |
Return on Equity (ttm) |
-95.2 |
Shares Out. (M) |
32.05 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-38.0 |
Shares Float (M) |
28.14 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
9.35 |
|
Forward EPS |
0.000 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
56 |
|
Book Value (p.s.) |
0.570 |
EBITDA (p.s.) |
-1.011 |
P/E |
-1.91 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
3.51 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
0.00 |
P/S |
712222208.00 |
|
Operating Margin |
-1087.63 |
Levered Free Cash Flow
(M) |
0.00 |
P/CF |
0.00 |
|
|
|
|
|
|
